Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 6/20 | 0.62 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.62 |
| ▸ | DRD1 | P21728 | 1/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.59 |
| ▸ | MLNR | O43193 | 1/20 | 0.59 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | AR | P10275 | 4/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13518370 | 0.88 | PGR (0.53) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| SCHEMBL7196456 | 0.88 | PGR (0.65) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| Delmadinone Acetate SCHEMBL146081 | 0.83 | NR3C1 (0.68) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| Delmadinone Acetate SCHEMBL146080 | 0.83 | NR3C1 (0.68) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| Chlormadinone SCHEMBL13358512 | 0.79 | PGR (0.78) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| Chlormadinone SCHEMBL37291 | 0.79 | PGR (0.78) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| SCHEMBL8859708 | 0.79 | CYP19A1 (0.60) | PGRNR3C1ADORA3NR1I2MLNR | |
| SCHEMBL11798369 | 0.79 | MEN1 (0.70) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| SCHEMBL13558387 | 0.79 | MEN1 (0.70) | PGRNR3C1CYP3A4DRD1OPRK1 | |
| SCHEMBL8974618 | 0.79 | MEN1 (0.70) | PGRNR3C1CYP3A4DRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 511 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4525938-B1 | RADIOPHARMACEUTICAL COMPLEXES TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND ITS COMBINATIONS | BAYER AG (DE) | 2026-03-11 | — | — | EP | claimed |
| WO-2023039125-A1 | ADENOSINE RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER | TEON THERAPEUTICS, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| EP-3400050-B1 | DRUG RELEASE DEVICE AND USE | JUROX PTY LTD (AU) | 2020-12-23 | — | — | EP | claimed |
| US-20190290474-A1 | DRUG RELEASE DEVICE AND USE | JUROX PTY LTD (AU) | 2019-09-26 | — | — | US | claimed |
| CN-109456381-A | A kind of preparation method of Delmadinone | 湖南科瑞生物制药股份有限公司 | 2019-03-12 | — | — | CN | claimed |
| CN-109456382-A | A method of preparing delmadinone acetate | 湖南科瑞生物制药股份有限公司 | 2019-03-12 | — | — | CN | claimed |
| CN-109369763-A | A kind of preparation method of delmadinone acetate product | 湖南科瑞生物制药股份有限公司 | 2019-02-22 | — | — | CN | claimed |
| CN-109369764-A | A kind of preparation method of delmadinone acetate | 湖南科瑞生物制药股份有限公司 | 2019-02-22 | — | — | CN | claimed |
| EP-3400050-A1 | DRUG RELEASE DEVICE AND USE | Jurox Pty. Ltd. (AU) | 2018-11-14 | — | — | EP | claimed |
| WO-2017117627-A9 | DRUG RELEASE DEVICE AND USE | JUROX PTY LTD (AU) | 2018-07-05 | — | — | WO | claimed |
| WO-2004058234-A2 | PHARMACEUTICAL COMBINATIONS OF PHTHALAZINE VEGF INHIBITORS AND BENZAMIDE HDAC INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-07-15 | — | — | WO | claimed |
| US-20040024230-A1 | Synthesis of cyproterone acetate | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-02-05 | — | — | US | claimed |
| WO-2003092578-A2 | FURTHER SYNTHESES OF CYPROTERONE ACETATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2003-11-13 | — | — | WO | claimed |
| EP-1359154-A1 | Further syntheses of cyproterone acetate | BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) | 2003-11-05 | — | — | EP | claimed |
| WO-2002057241-A1 | 8-(AMINOALKOXYMINO)-8H-DIBENZO[a,e]TRIAZOLO[4,5-c]CYCLOHEPTENES AS GROWTH HORMONE SECRETAGOGUES | BAYER PHARMACEUTICALS CORPORATION (US) | 2002-07-25 | — | — | WO | claimed |
| WO-2002056873-A2 | 2-SUBSTITUTED DIBENZO[A,E]1,2,3-TRIAZOLO[4,5-C][7]ANNULEN-8-ONES AS GROWTH HORMONE SECRETAGOGUES | BAYER PHARMACEUTICALS CORPORATION (US) | 2002-07-25 | — | — | WO | claimed |
| JP-2002522389-A | — | — | 2002-07-23 | — | — | JP | claimed |
| EP-1102590-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION | MERCK SHARP & DOHME LTD. (GB) | 2001-05-30 | — | — | EP | claimed |
| US-6043026-A | MIXTURE OF AN ESTROGEN RECEPTOR MODULATOR AND A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 2000-03-28 | — | — | US | claimed |
| WO-2000007598-A1 | USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION | MERCK SHARP & DOHME LIMITED (GB) | 2000-02-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024230-A1 | Synthesis of cyproterone acetate | CYP17A1, CYP19A1, CYP21A2 | PGR 78/4885NR3C1 157/4885CYP3A4 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.